Precigen, Inc. (PGEN)
4.38
-0.13
(-2.88%)
USD |
NASDAQ |
Feb 20, 16:00
4.38
0.00 (0.00%)
After-Hours: 20:00
Precigen Shareholders Equity (Quarterly) : 41.87M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 18.39M |
| Amneal Pharmaceuticals, Inc. | -109.46M |
| Corcept Therapeutics, Inc. | 631.90M |
| ADMA Biologics, Inc. | 431.19M |
| Viridian Therapeutics, Inc. | 502.97M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 171.26M |
| Total Liabilities (Quarterly) | 129.40M |
| Debt to Equity Ratio | 2.345 |
| Current Ratio | 4.041 |
| Net Debt Paydown Yield | -1.58% |